Abstract 165P
Background
Lung cancer is the most common cancer in men (14.3%) and 3rd most common cancer in female (8.4%) but account for overall highest cancer related mortality (18%). In India, lung cancer is 4th most common cancer both in incidence and cancer related death. NSCLC is the most common type accounting about 80-85% cases and among these adenocarcinoma accounts for more than half and is further defined according to different molecular subtypes by the identification of oncogenic drivers. With recent advances in the knowledge of NSCLC biology, various oncogenic driver mutations are identified which causes aberrant activation of intracellular signaling pathways associated with the sustained growth of lung cancer cells. Research objectives: Evaluation the mutational profile of NSCLC with broad panel-based next-generation sequencing.
Methods
The study was a hospital based prospective, cross sectional descriptive study conducted at a tertiary care center in Northeast India done during the period from 1st january,2022 to 31st December,2022. Ninteen cases of histologically proven meatstatic NSCLC in core biopsy were included in this study.
Results
The age of patients with NSCLC in our study ranged from 48 to 80 years with mean age of 64.36(+/-9.82) years. Majority of the patients in our study were from the age category 71-80 years (37%) Male to female ratio was 19:1 (95% vs 5%). 73.3% of cases were chronic smokers while 26.3% were nonsmokers with smoker non-smoker ratio of 2.79:1.100% of cases presented in late stage (Stages IV). Regarding biomarker profile of NSCLC in our study, EGFR mutation positivity was seen in 10.5%.ALK rearrangement was positive in 5.3% of patients. In our study PD-L1 expression positivity was57.9% and among these patients,18.2% has TPS>50% whereas 81.8% showed TPS<50%.
Conclusions
Adenocarcinoma is the predominant histological subtype of NSCLC in the region of NE India, with a high proportion of cases harboring EGFR mutation. Moreover, NSCLC is characterized with unique mutations and cannot be generalized in larger context. So, study with larger sample size should be encouraged for evaluation of molecular profile of NSCLC in this region.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
Assam Medical College, Dibrugarh.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
72P - Role of pyruvate carboxykinase 2 upregulation in group 3 medulloblastoma: Implications for metabolic reprogramming and therapeutic strategies
Presenter: MEDHA GAYATHRI PAI
Session: Cocktail & Poster Display session
Resources:
Abstract
73P - Effect of combination therapy with atezolizumab plus metformin on peripheral immune cells from NSCLC patients
Presenter: Luisa Amato
Session: Cocktail & Poster Display session
Resources:
Abstract
74P - Obesity regulates tumor progression and sensitivity to checkpoint blockade through the diet-microbiota-immunity axis
Presenter: Lysanne Desharnais
Session: Cocktail & Poster Display session
Resources:
Abstract
75P - Possible significance of the proline at position 325 in the recognition of the MX35 epitope of the NaPi2b transporter by monoclonal antibodies
Presenter: Leisan Bulatova
Session: Cocktail & Poster Display session
Resources:
Abstract
76P - Circadian control of neutrophil extracellular trap formation temporally regulates metastatic lung cancer progression
Presenter: Simon Milette
Session: Cocktail & Poster Display session
Resources:
Abstract
78P - Daily rhythmic expression of pro-tumoral programs in NSCLC shape cancer immunity and therapy response
Presenter: Alba de Juan
Session: Cocktail & Poster Display session
Resources:
Abstract
79P - Tumor cell-released autophagosomes (TRAPs) remodel the breast tumor microenvironment by inducing the formation of inflammatory cancer-associated fibroblasts (CAFs)
Presenter: Chengdong Wu
Session: Cocktail & Poster Display session
Resources:
Abstract
80P - Tumor microenvironment (TME) defines prognosis of EGFR-mutant non-small cell lung cancer (NSCLC)
Presenter: Lodovica Zullo
Session: Cocktail & Poster Display session
Resources:
Abstract
81P - Single-cell spatial landscape of NSCLC reveals subtype specific immune features
Presenter: Mark Sorin
Session: Cocktail & Poster Display session
Resources:
Abstract
82P - Tumor cell-released autophagosomes (TRAPs) promote breast cancer lung metastasis by modulating neutrophil extracellular traps formation
Presenter: XIAOHE ZHOU
Session: Cocktail & Poster Display session
Resources:
Abstract